Evolution of hypofractionated stereotactic irradiation for radio-resistant brain metastases from D1-3-5 to D1-2-3
Study description
A prospective, double-arm clinical trial to demonstrate the benefit of a condensed treatment schedule of hypofractionated stereotactic radiotherapy in patients with brain metastases from radioresistant primary tumors.
Key results
Under development
